Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour.

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

The research, published in Proceedings of the National Academy of Sciences and coauthored by UC San Diego School of Biological Sciences Assistant Professor Uri Manor, highlights the new drug’s ...

While interest in psychedelics has resurged in recent years, LSD remains too unpredictable for vulnerable populations, particularly those with schizophrenia. Now, scientists at the University of ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases ...

Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering ...

Smoking cannabis affects brain chemistry so seriously it can trigger schizophrenia, scientists warn today. Researchers have found the first evidence that marijuana can cause genetic abnormalities ...

New Delhi, April 15 (IANS) Rising temperatures may not only affect physical health, but could also increase the burden of mental and behavioural disorders (MBD) like schizophrenia and depression ...

A novel schizophrenia treatment shows promising efficacy and safety, targeting specific pathways for symptom management. Clinical trials reveal significant improvements in symptom control and ...